Clinical features of adult-onset chronic active Epstein-Barr virus infection: a retrospective analysis.

International journal of hematology

Volumn 93, Issue 5, 2011, Pages 602-609

  Arai, Ayako ^a   Imadome, Ken Ichi ^b   Watanabe, Yuko ^b   Yoshimori, Mayumi ^b   Koyama, Takatoshi ^b   Kawaguchi, Takeharu ^b   Nakaseko, Chiaki ^b   Fujiwara, Shigeyoshi ^b   Miura, Osamu ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; CASE REPORT; DRUG ADMINISTRATION; DRUG EFFECT; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; HUMAN; JAPAN; MALE; MIDDLE AGED; MORTALITY; ONSET AGE; PATHOPHYSIOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT FAILURE; VIROLOGY;

ADULT; AGE OF ONSET; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; JAPAN; MALE; MIDDLE AGED; PREDNISONE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT FAILURE; VINCRISTINE;

EID: 80052919943     PISSN: None     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-011-0831-x     Document Type: Article

References (0)